Operating

Change in AR

Regeneron Pharmaceuticals Change in AR increased by 99.8% to -$1.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 99.8%, from -$657.80M to -$1.20M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 29, 2026

How to read this metric

A decrease is generally positive as it indicates faster collection of cash from customers.

Detailed definition

This measures the change in the amount of money owed to the company by customers for goods or services delivered on cred...

Peer comparison

Standard metric for all companies; peers in medical devices monitor this closely to manage working capital cycles.

Metric ID: change_in_accounts_receivable

Historical Data

14 periods
 Q2 '21Q4 '21Q1 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q1 '26
Value$2.83B$584.50M-$1.20B-$219.60M-$210.10M$2.70M$463.50M$82.70M-$446.80M$494.10M$388.90M$117.80M-$657.80M-$1.20M
QoQ Change-79.3%-304.9%+81.7%+4.3%+101.3%>999%-82.2%-640.3%+210.6%-21.3%-69.7%-658.4%+99.8%
YoY Change-137.6%+82.5%+137.7%-112.7%>999%-16.1%+42.4%-47.2%+99.8%
Range-$1.20B$2.83B
CAGR-90.8%
Avg YoY Growth>999%
Median YoY Growth+42.4%

Frequently Asked Questions

What is Regeneron Pharmaceuticals's change in ar?
Regeneron Pharmaceuticals (REGN) reported change in ar of -$1.20M in Q1 2026.
How has Regeneron Pharmaceuticals's change in ar changed year-over-year?
Regeneron Pharmaceuticals's change in ar increased by 99.8% year-over-year, from -$657.80M to -$1.20M.
What does change in ar mean?
The change in money owed to the company by customers for past sales.